Literature DB >> 12502861

Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Monica A McArthur1, Miguel T Suderman, John-Paul Mutebi, Shu-Yuan Xiao, Alan D T Barrett.   

Abstract

A hamster viscerotropic strain of yellow fever (YF) virus has been derived after serial passage of strain Asibi through hamsters. The parental Asibi/hamster p0 virus causes a mild and transient viremia in hamsters with no outward, clinical signs of illness. In contrast, the viscerotropic Asibi/hamster p7 virus causes a robust viremia, severe illness, and death in subadult hamsters. The genome of the hamster viscerotropic Asibi/hamster p7 virus has been sequenced and compared with the parental nonviscerotropic Asibi/hamster p0 virus identifying 14 nucleotide changes encoding only seven amino acid substitutions. The majority of these substitutions (five of seven) fall within the envelope (E) protein at positions Q27H, D28G, D155A, K323R, and K331R. These results support an important role for the E protein in determining YF virus viscerotropism.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502861      PMCID： PMC140822          DOI： 10.1128/jvi.77.2.1462-1468.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  35 in total

1.  Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.

Authors:  L M Dunster; H Wang; K D Ryman; B R Miller; S J Watowich; P D Minor; A D Barrett
Journal:  Virology       Date:  1999-09-01       Impact factor: 3.616

2.  Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa.

Authors:  J P Mutebi; H Wang; L Li; J E Bryant; A D Barrett
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  The machinery for flavivirus fusion with host cell membranes.

Authors:  F X Heinz; S L Allison
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

4.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccine.

Authors:  R C Chan; D J Penney; D Little; I W Carter; J A Roberts; W D Rawlinson
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

5.  Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases.

Authors:  P F Vasconcelos; E J Luna; R Galler; L J Silva; T L Coimbra; V L Barros; T P Monath; S G Rodigues; C Laval; Z G Costa; M F Vilela; C L Santos; P M Papaiordanou; V A Alves; L D Andrade; H K Sato; E S Rosa; G B Froguas; E Lacava; L M Almeida; A C Cruz; I M Rocco; R T Santos; O F Oliva; C M Papaiordanou
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

6.  Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

Authors:  M Martin; T F Tsai; B Cropp; G J Chang; D A Holmes; J Tseng; W Shieh; S R Zaki; I Al-Sanouri; A F Cutrona; G Ray; L H Weld; M S Cetron
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

7.  Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology.

Authors:  S Y Xiao; H Zhang; H Guzman; R B Tesh
Journal:  J Infect Dis       Date:  2001-04-17       Impact factor: 5.226

8.  Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.

Authors:  Thomas P Monath; Juan Arroyo; Inessa Levenbook; Zhen-Xi Zhang; John Catalan; Ken Draper; Farshad Guirakhoo
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity.

Authors:  L Qu; L K McMullan; C M Rice
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  Structures and mechanisms in flavivirus fusion.

Authors:  F X Heinz; S L Allison
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937
View more
  19 in total

1.  Mutational analysis of the West Nile virus NS4B protein.

Authors:  Jason A Wicker; Melissa C Whiteman; David W C Beasley; C Todd Davis; Charles E McGee; J Ching Lee; Stephen Higgs; Richard M Kinney; Claire Y H Huang; Alan D T Barrett
Journal:  Virology       Date:  2012-02-06       Impact factor: 3.616

2.  Genomic and phylogenetic characterization of Brazilian yellow fever virus strains.

Authors:  Marcio R T Nunes; Gustavo Palacios; Jedson F Cardoso; Livia C Martins; Edivaldo C Sousa; Clayton P S de Lima; Daniele B A Medeiros; Nazir Savji; Aaloki Desai; Sueli G Rodrigues; Valeria L Carvalho; W Ian Lipkin; Pedro F C Vasconcelos
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

3.  Murine model for dengue virus-induced lethal disease with increased vascular permeability.

Authors:  Sujan Shresta; Kristin L Sharar; Daniil M Prigozhin; P Robert Beatty; Eva Harris
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 4.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

5.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

6.  Molecular Characterization of Hamster-Adapted Yellow Fever Virus.

Authors:  Monica A McArthur; Shuliu L Zhang; Li Li; Robert B Tesh; Alan D T Barrett
Journal:  Vector Borne Zoonotic Dis       Date:  2019-12-02       Impact factor: 2.133

7.  Current Assessment of Yellow Fever and Yellow Fever Vaccine.

Authors:  Anabelle Lefeuvre; Philippe Marianneau; Vincent Deubel
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 8.  Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention.

Authors:  Joanna Zmurko; Johan Neyts; Kai Dallmeier
Journal:  Rev Med Virol       Date:  2015-04-01       Impact factor: 6.989

Review 9.  Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.

Authors:  Luděk Eyer; Radim Nencka; Erik de Clercq; Katherine Seley-Radtke; Daniel Růžek
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

10.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.